Ultrastructural and biochemical alterations induced by 22,26-azasterol, a Δ24(25)-sterol methyltransferase inhibitor, on promastigote and amastigote forms of Leishmania amazonensis

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 2, 2002, Pages 487-499

  Rodrigues, Juliany C F ^a   Attias, Márcia ^a   Rodriguez, Carlos ^a   Urbina, Julio A ^a   De Souza, Wanderley ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

22,26 AZASTEROL; ANTILEISHMANIAL AGENT; DELTA 24(25) STEROL METHYLTRANSFERASE; ENZYME INHIBITOR; KETOCONAZOLE; METHYLTRANSFERASE; STEROL; STEROL DERIVATIVE; UNCLASSIFIED DRUG; ZYMOSTEROL;

AMASTIGOTE; ANTIPROTOZOAL ACTIVITY; ARTICLE; BIOCHEMISTRY; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; FLAGELLUM; LEISHMANIA; MITOCHONDRIAL MEMBRANE; MITOCHONDRION SWELLING; NONHUMAN; PRIORITY JOURNAL; PROMASTIGOTE; STEROL ANALYSIS; STEROL SYNTHESIS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTIFUNGAL AGENTS; CELL DIVISION; CHOLESTANOL; DRUG INTERACTIONS; ENZYME INHIBITORS; KETOCONAZOLE; LEISHMANIA; LIPIDS; METHYLTRANSFERASES;

EID: 0036148605     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.2.487-499.2002     Document Type: Article

References (66)

1. The role of polyamines in the neutralization of deoxyribonucleic acid
2. Biochemical aspects of ergosterol biosynthesis inhibition
3. Pneumocystis carinii, an opportunist in immunocompromised patients
4. Pneumocystis carinii is resistant to imidazole antifungal agents
5. Lipids of Leishmania promastigotes
6. Effects of antimycotic azoles on growth and sterol biosynthesis of Leishmania promastigotes
7. Activity of imidazoles against Leishmania tropica in human macrophage cultures
8. Effects of ketoconazole on growth and sterol biosynthesis of Leishmania mexicana promastigotes in culture
9. Effects of ketoconazole on sterol biosynthesis by Leishmania mexicana mexicana amastigotes in murine macrophage tumor cells
10. Chemotherapy of leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies
11. Drug discovery: A chemist approach
12. Altered lipid composition and enzyme activities of plasma membranes from Trypanosoma (Schizotrypanum) cruzi epimastigotes grown in the presence of sterol biosynthesis inhibitors
13. Recent advances in the biology of Pneumocystis carinii
14. Quantitative thin layer chromatography of lipids
15. Liposomal amphotericin B in drug-resistant visceral leishmaniasis
16. 2+ storage compartment in trypanosomatids and apicomplexan parasites
17. Sterols of Leishmania species. Implications for biosynthesis
18. Effects of an azasterol inhibitor of 24-transmethylation on sterol biosynthesis and growth of Leishmania donovani promastigotes
19. Antimycotic imidazoles. Part 4. Synthesis and antifungal properties of ketoconazole, a new potent orally active broad-spectrum antifungal agent
20. Programs for visualization in three-dimensional microscopy
21. Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi
22. Ultrastructural alterations induced by ICI 195,739, a bis-triazole derivate with strong antiproliferative action against Trypanosoma (Schizotrypanum) cruzi
23. Sterol composition and biosynthesis in Trypanosoma cruzi amastigotes
24. Drug effects on the fine structure of Trypanosoma rhodesiense: Suramim, tryparsamide and mapharside
25. Pentavalent antimonials: Old drugs for new diseases
26. Clinical manifestations, diagnosis and treatment of leishmaniasis
27. Prevention and treatment of Pneumocystis pneumonia
28. Inhibitors of sterol biosynthesis and their applications
29. The fine structure of acidocalcisomes in Trypanosoma cruzi
30. Placebo-controlled clinical trial of sodium stibogluconate (Pentostan) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala
31. Rationally designed inhibitors of sterol biosynthesis
32. Practical progress and new drugs for changing patterns of leishmaniasis
33. Developmental life cycle of Leishmania-cultivation and characterization of cultured extracellular amastigotes
34. Allylamine derivates: New class of synthetic antifungal agents inhibiting fungal squalene epoxidase
35. Fine structure and cytochemistry of the endoplasmic reticulum and its association with the plasma membrane of Leishmania mexicana amazonensis
36. Inhibition of sterol biosynthesis in higher plants by analogues of high energy carbocationic intermediates
37. Naturally azole-resistant Leishmania braziliensis promastigotes are rendered susceptible in the presence of terbinafine. A comparative study with azolesusceptible Leishmania mexicana
38. Inhibitors of phospholipid biosynthesis
39. The sterol composition of Trypanosoma cruzi changes after growth in different culture media and results in different sensitivity to digitonin permeabilization
40. Effect of the antimycotic drug naftifine on growth and sterol biosynthesis in Candida albicans
41. Specific inhibition of fungal steroid biosynthesis by SF-86327, a new allylamine antimycotic agent
42. Effect of allylamine antimycotic agents on sterol biosynthesis measured by sterol side-chain methylation
43. Inhibition of squalene epoxidase by allylamine antimycotic compounds. A comparative study of the fungal and mammalian enzymes
44. Mechanism of action and biochemical selectivity of allylamine antimycotic agents
45. The biology of Pneumocystis carinii
46. Endocytosis of gold-labeled proteins and LDL by Trypanosoma cruzi
47. Mechanism of action of antimycotic imidazoles
48. Heterogeneity of action mechanisms among antimycotic imidazoles
49. In vitro potency and in vivo activity of azoles
50. Antiproliferative synergism of the allylamine SF 86-327 and ketoconazole on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi
51. Molecular order and dynamics of phosphatidylcholine bilayer membranes in the presence of cholesterol, ergosterol and lanosterol-a comparative study using 2H-, 13C- and 31P-NMR spectroscopy
52. 24(25)-sterol methyltransferase inhibitors and their combinations with ketoconazole
53. 24(25)-sterol methyltransferase inhibitors on Trypanosoma (Schizotrypanum) cruzi: In vitro and in vivo studies
54. Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites
55. 24(25)-sterol methyltransferase block sterol synthesis and cell proliferation in Pneumocystis carinii
56. Biochemical effects of miconazole in fungi. II. Inhibition of ergosterol biosynthesis in Candida albicans
57. In vitro and in vivo effects of the antimycotic drug ketoconazole on sterol synthesis
58. Cytochrome P-450: Target for itraconazole
59. Basis for the search of new antifungal drugs
60. Leishmanial protein kinase C modulates host cell infection via secreted acid phosphatase
61. Alterations induced by the antifungal compounds ketoconazole and terbinafine in Leishmania
62. Impairment of sterol biosynthesis leads to phosphorus and calcium accumulation in Leishmania acidocalcisomes
63. 24(25)-sterol methyltransferase inhibitors and their combinations with ketoconazole
64. The flagellar pocket of trypanosomatids
65. Treatment of leishmaniasis and trypanosomiasis
66. Three-dimensional reconstruction from serial micrographs using an IBM PC